In 22 patients about to undergo cardiac surgery, a study was made of the effects of variations in circulation time on the neuromuscular action of suxamethonium. There was a definite rdationship between the arm-toarm circulation time and the time from the injection of suxamethonium to the onset of action, and to the development of 95% depression of the evoked twitch tension in the hypothenar muscles. The circulation time also related to the presence and vigour of fasciculations but not to the duration of action of suxamethonium. The clinical implications are discussed.
INTRODUCTION
There has been considerable investigation of the effect of neuromuscular relaxants on cardio-vascular function, but very little study of the converse effect of variations in circulatory status on the neuromuscular blocking actions of the relaxants. In the case of suxamethonium, the most pertinent study is that of G. G. Harrison (1966) . He showed that a dos2 of 50 mg produced a lower incidence of muscular fasciculations and a higher incidence of inadequate laryngeal relaxation in patients with mitral valve disease than in those with aortic valve disease or atrial septal defect. By studying the preoperative dye dilution curve, he demonstrated that lack of muscle fasciculations was related to the dye build-up time to peak concentration. He also suggested that with a slow circulation there might be longer than usual exposure of the drug to pseudocholin-esterase, and this might lead to a shortened action. He recommended that in patients with a slow circulation a dose larger than usual (100 mg) should be used and that as the onset of fasciculations was delayed, the anaesthetist should be prepared to wait longer than usual following the injection before attempting intubation. However, as the dye dilution curves were performed at intervals ranging from a few days to many months before the operation, and no study was made of neuromuscular events other than fasciculations, he was unable to investigate more closely the relationship of circulatory dynamics to suxamethonium action. This paper describes a study of the relationship between circulation time (and cardiac output) measured after the induction of anaesthesia and the course of some neuromuscular events with suxamethonium.
METHOD OF INVESTIGATION
The physical state, type of operation and preoperative cardiac index of 22 patients undergoing various operations requiring cardiopulmonary bypass are shown in Table 1 .
Premedication consisted of pethidine hydrochloride 50-75 mg, promethazine 12 ·5-25 mg, and hyoscine 0·2mg given It to 2t hours preoperatively. Before induction, a 15G Braun cannula with a rubber covered bung was inserted into a vEin in the right arm. The vein was always within three inches of the wrist to minimize the effect on the cardio-vascular studies of variations in injection site.
A 17G Dwellcath was passed percutaneously into the left radial artery and connected to a Statham P23Db pressure transducer, displayed on an E for M PR7 oscilloscope with preamplifying circuits and recorded on a Both series 100 direct pen writer. After at least three minutes preoxygenation, sodium thiopentone (3-5 mg/kg) was injected through the 3.1 G. A. HAlmIS():\ A:\Tl F. JUK!\'S venous cannula. This was followed by 5 mg of indocyanine green (Cardiogreen) in water from a 1 ml tuberculin syringe injected through a ~IG needle as rapidly as possible. It was immediately flushed with f) ml of saline. Pressure recording was interrupted and arterial blood was withdrawn from the left radial arterv bv a Harvard pump at the rate of 27 ml/min ~nd the resultant dye-dilution curve recorded via a Gilford densitor;1eter on a San borne two-channel recorder. Appearance time of the dye from right to left wrist was measured from the moment of injection of the dye to tbe onset of rise from zero of the dye concentration. Cardiac output was derived in the standard fashion using the technique of replotting the downslope of the dye dilution curve on semi-logarithmic paper before measuring the area under the curve. )JEURO~Il'SCC;LAR STUDIES Before induction, external electrodes were fixed over the right ulnar nerve behind the elbow. After the thiopentone, but before the injection of the Cardiogreen, the right ring finger was fixed to a Grass FT03 force transducer. The nerve was stimulated with supramaximal square wave stimuli of O' 2 msec duration at 16 per minute, and the force of contraction recorded on the Both series 100 direct pen writer. After the injection of the Cardiogreen, suxamethonium 1 mg/kg was injected through a 21G needle as rapidly as possible into the venous cannula and flushed with .5 ml of saline. The following were recorded. 
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"ilzaestizesill alld IlItclIsi,'" Care, "01. I, X(). 1, ~illKUS/, 1.'I7:! was also taken as the time from injection to suitable intubating conditions. (b) The time from injection of the suxamethonium to the first sign of neuromuscular effect. (Interval 1-2, Figures  1 and 2 
.)
When the onset of fasciculations did not markedly disturb the base line or height of the twitch response, the onset was taken as the first depression of twitch height (Figure 1 ). When the onset of fasciculations was apparent on the twitch \Vhen there was evidence of the return of neuromuscular transmission by hypothenar twitch or generalized muscle actiyity', a non-depolarizer (alcuroniulll or pancuronium) was injected and the time from the onset of neuromuscular effect to the injection of the nondepclarizer was measured (Interyal 2-4, Figure 1 ) and from the injection of the suxamethoniulll to the injection of the non-depolarizer. (Inten'aI1-4, Figure 1 .) (c) Fasciculations were classified as very brisk (if they were yiolcnt), brisk, moderat'e (if they were present but slight), or absent. (j) The ease of intubation.
The movements of the cords as affected by laryngoscopy and the first contact "'itlt the endotracheal tube were ncted. THE Sl:XA:\[ETHOl\IC~I The ::;uxamethonium chloride ampoules were from a batch which had been specifically freshly prepared by the manufacturers (Burroughs Wellcome & Co. (Aust.).) They were kept in a refrigerator at 4 0 C from the time of preparation. The study occupied two months, and the batch was used only for patients in the study. The dose of 1 mgjkg for each patient was drawn up approximately 15 minutes before induction and allowed to come to room temperature.
To assess whether anv breakdown of suxamethonium had occurr~d during the study, samples from the batch were assayed by the method in the British Pharmacopoeia (1968). After the sixteenth and last patients no breakdown products were found.
RESULTS
The appearance time of the dye from the vein on the right wrist to the artery in the left wrist ,'aried from 21·3 to 49·6 seconds (Table 2) . I t seems reasonable to assume that the appearance time was greater than the equiYalent cirC'Ulation time b" the time for the dye to pass There was no difficulty in the measurement of appearance time, but there was some difficulty in the accurate measurement of the cardiac output. In several cases (1, 14, 15 and 17) in whom there were obviously depressed circulatory dynamics, the downslope of the dye curve was slow and flat, so that it was difficult to rep lot and measure the area under the curve with complete confidence. This was not unexpected in view of the peripheral sites of injection and sampling of the dye. It was therefore more appropriate to compare appearance time (circulation time) rather than cardiac output with the neuromuscular events. depression. Thus in 21 patients the mean time was 80·9 seconds (S.D. 24·0; S.E.M. 5·2 ; range 54-142). There was good correlation (Figure 3 ) with the appearance time (r=0'89, y=2 ·98x-12 '91) and this was highly significant (P<O·OOl). (r=0'91, y=2'22x-28'18) and this was highly significant (P<O·OOl).
(c) Time from first sign of neuromuscular effect (first change of twitch height) to 95% depression of twitch height (Case 22 excluded).
The mean time was 39·8 seconds (S.D. 8·6; S.E.M. 1·8; range 28-60). There was reasonable correlation ( Figure 5 ) with appearance time (r=0·63, y=0'76x+15'9) and this was significant (P<0·002). FASCICULA TIO:-\S There were three patients who did not fasciculate (Table 2) . They were the patients with the longest appearance times (49,6, 43·1 and 40·0 seconds respectively). In general, those with short appearance times had the most marked fasciculations (Table 2) , but there was some variation. Several patients with short appearance times had only moderate fasciculations, and some with intermediate appearance times had brisk (but never violent) fasciculations. The mean time was 175·5 seconds (S.D. 71'4; S.E.M. 15·6; range 84-352). There was no correlation with appearance time (Figure 6, r=0·07) . An impression was gained that the action of suxamethonium was shortest in the very fit and the very ill in terms of circulatory status, but a much larger series would be required to establish this.
(e) Total time from injection of suxamethonium to the injection of non-depolarizer (Case 22 excluded).
The mean time was 216·7 seconds (S.D. 71 ·7 ; S.E.M. 15·6; range 114-396). There was no correlation with appearance time (r=O· 29).
CO~DITIONS FOR INTUBATION
The patient who reached 85% depression of twitch height only was impossible to intubate and a non-depolarizer was given immediately. The patient who reached 95% depression only was moving his shoulders actively during intubation but intubation was otherwise relatively easy. In the rest, intubation was easy but there was often slight movement of the cords or limbs during intubation. This did not appear related to appearance time, but rather to the age and general muscular build of the patient, these responses occurring more frequently in the younger, more muscular patients . The changes in blood pressure were the same as those described in detail in a previous study (G. A. Harrison 1972) . There was a fall after the thiopentone, a rise after the suxamethonium, and a further rise after intubation.
DrscussIO)!
The circulatory status clearly affected the neuromuscular response to suxamethonium (1 mg/kg) at least in the peripheral muscles studied. As circulation time slowed, there was an increase in the total time from the injection to 95% depression of evoked twitch. There were two components to this increase. The time from injection to the onset of neuromuscular effect was lengthened. Visible fasciculations were absent or very slight. This confirms the findings of G. G. Harrison (1966) . The second component of the increased time was the slower rate of fall in twitch height after the onset of neuromuscular effect as the circulation time increased.
However, the correlation between the second component and the circulation time was not as good as the correlation between the circulation time and the time to the onset of twitch depression. It seems likely that the second component was affected by factors other than the circulatory status, including, possibly, the amount of suxamethonium in relation to the total muscle mass. The lack of correlation between circulation time and duration of the suxamethonium block suggests that the important factors were: the balance between the amount of suxamethonium, the muscle mass, and the exposure of the suxamethonium to pseudocholinesterase. This was supported by the tendency for the shorter durations of block to occur in the very fit with short circulation times and the very iil with prolonged circulation times. In the first group there was usually good muscular development; in the second group the longer exposure of the drug in the blood to pseudocholinesterase may have caused less drug to reach the end plates (G. G. Harrison 1966) ; but vyith intermediate prolongation of circulation time there was no evidence of shortening of action.
There are important implications derived from this study for those administering suxamethonium to patients with severe cardiac disease with a prolonged circulation time.
It is quite likely that these considerations also apply to patients with other types of circulatory depression.
(1) The time from injection to maximum neuromuscular block may be very much delayed (up to 2t minutes instead of less than 1 minute in this study), and the usual sign of onset (fasciculations) may be not only delayed but also slight or absent. Failure to allow sufficient time for the onset explains the not rarely seen picture in poor risk patients of mild fasciculations occurring after the start of laryngoscopy or even after intubation. Sometimes intubation is accomplished in a non-relaxed patient, and then a period of complete relaxation ensues. Adequate time must be given for the development of maximum block if it is feared that premature laryngoscopy might precipitate struggling or vomiting.
(2) There is probably some merit in having a peripheral nerve stimulator in place during induction, if these changes in the times to neuromuscular events are considered a likelv problem. .
(3) In the majority of cases 1 mg/kg suxamcthonium is an adequate dose for good intubating conditions in an acceptable time, even with a slowed circulation. However, if it is felt essential that perfect intubating conditions be present in a particular patient with a poor circulation, then a larger dose should be selected. Thought must then be given to the other circulatory effects of suxamethonium such as arrhythmlas and hypertension. Doses smaller than 1 mg/kg may produce inadequate block in patients with a slow circulation.
(4) In considering other relaxants as alternatives to suxamethonium, the effect of variations in circulation time on their action must be investigated. This is particularly important when the relaxants are being compared for their suitability in the poor-risk patient with a full stomach.
